Current Liabilities
Compensation and benefits
Edwards Lifesciences Compensation and benefits decreased by 43.2% to $265.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.0%, from $232.80M to $265.40M. Over 5 years (FY 2020 to FY 2025), Compensation and benefits shows an upward trend with a 14.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ4 2025
Last reportedQ1 2026
How to read this metric
Significant increases may reflect higher headcount, increased compensation, or timing differences in bonus payouts, while decreases could signal cost-cutting or reduced workforce.
Detailed definition
This includes short-term obligations to employees, such as accrued wages, bonuses, vacation pay, and other benefits due...
Peer comparison
Commonly reported by labor-intensive companies, particularly in services and logistics.
Metric ID:
current_liabilities_employee_related_liabilities_currentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $262.20M | $325.00M | $319.70M | $221.70M | $256.00M | $250.00M | $268.70M | $225.80M | $312.70M | $340.00M | $371.20M | $237.20M | $288.70M | $312.10M | $358.60M | $232.80M | $352.70M | $437.40M | $467.50M | $265.40M |
| QoQ Change | — | +24.0% | -1.6% | -30.7% | +15.5% | -2.3% | +7.5% | -16.0% | +38.5% | +8.7% | +9.2% | -36.1% | +21.7% | +8.1% | +14.9% | -35.1% | +51.5% | +24.0% | +6.9% | -43.2% |
| YoY Change | — | — | — | — | -2.4% | -23.1% | -16.0% | +1.8% | +22.1% | +36.0% | +38.1% | +5.0% | -7.7% | -8.2% | -3.4% | -1.9% | +22.2% | +40.1% | +30.4% | +14.0% |
Range$221.70M – $467.50M
CAGR+0.3%
Avg YoY Growth+9.2%
Median YoY Growth+3.4%
Compensation and benefits at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's compensation and benefits?
- Edwards Lifesciences (EW) reported compensation and benefits of $265.40M in Q1 2026.
- How has Edwards Lifesciences's compensation and benefits changed year-over-year?
- Edwards Lifesciences's compensation and benefits increased by 14.0% year-over-year, from $232.80M to $265.40M.
- What is the long-term trend for Edwards Lifesciences's compensation and benefits?
- Over 5 years (2020 to 2025), Edwards Lifesciences's compensation and benefits has grown at a 14.6% compound annual growth rate (CAGR), from $236.70M to $467.50M.
- What does compensation and benefits mean?
- Short-term debts owed to employees for wages, bonuses, and benefits.